Achieve Life Sciences, Inc. (FRA:SP4P)

Market Cap	596.38M +165.2%
Revenue (ttm)	n/a
Net Income	-99.82M
EPS	-1.62
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	286
Open	5.70
Previous Close	5.70
Day's Range	5.70 - 5.70
52-Week Range	2.29 - 7.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Achieve Life Sciences

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Andrew Goldberg
• Employees: 28
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SP4P

Financial Performance

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error